2026
article
OpenAlex
Salman J. Khan, Hamza Usman, Seemab Sheikh, Kelvin Rojas et autres
e19095 Background: Richter transformation (RT), the progression of chronic lymphocytic leukemia to aggressive diffuse large B-cell lymphoma, carries poor outcomes. Chemoimmunotherapy (CIT), including R-CHOP, remains commonly used in the frontline setting, while CD19-directed CAR T-cell therapy is used mainly in relapsed/refractory (R/R) …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Muhammad Rizwan Tariq, Blessing T Ojinna, Efrah Ashraf, Arshia Ahmed et autres
Primary pulmonary and thyroid diffuse large B-cell lymphoma (DLBCL) is an exceptionally rare extranodal manifestation of non-Hodgkin lymphoma and often presents with nonspecific clinical and radiographic features, leading to significant diagnostic challenges. We report a case of a 70-year-old woman with extensive …
pk, us
(code pays fourni par la source)
2026
article
OpenAlex
Salman J. Khan, Hamza Usman, Seemab Sheikh, Mahuri Yalamanchili
us
(code pays fourni par la source)
2026
article
OpenAlex
Awais Aslam, Wahab Jahangir Khan, Syed H. Haq, Ifrah Nadeem et autres
Cardiac sarcoidosis (CS) is a rare and complex disease that requires a multidisciplinary approach for diagnosis and treatment. The diagnosis of CS can be confirmed by histological examination of non-caseating granulomas in cardiac or extracardiac tissue, along with supportive clinical and imaging …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Hafiz Muhammad Asif Javed, Fatima Sial, Farooq Ashraf, Aman Ullah et autres
Abstract Introduction: Chimeric Antigen Receptor (CAR) T-cell therapy has transformed the treatment of relapsed or refractory B-cell malignancies. Repeat CAR T-cell therapy (CART2) is a potential approach for patients with suboptimal response to initial treatment or who relapse. Here we report outcomes …
us, pk
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Divya Chukkalore, Phyu Thin Naing, Kelvin Zheng, Richa Thakur et autres
Abstract Background Teclistamab, a BCMA x CD3 bispecific antibody, is a highly effective novel therapeutic option for patients with relapsed/refractory multiple myeloma (RRMM). Clinical trials like MajesTEC-1 show impressive efficacy but also high early infection rates, likely due to immune disruption from …
us, Afrique du Sud
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Moazzam Shahzad, Muhammad Shaheer Mannan, Hafiz Muhammad Asif Javed, Farooq Ashraf et autres
Abstract Background Hyperhemolysis syndrome (HHS) is a rare, potentially fatal transfusion complication seen in patients with sickle cell disease (SCD), characterized by the destruction of both donor and recipient red blood cells, leading to a paradoxical drop in hemoglobin. Eculizumab, a monoclonal …
us, pk
(code pays fourni par la source)
2025
article
OpenAlex
Ammad Naeem, Fatima Sial, Salman J. Khan, Aniqa Faraz et autres
2025
conference-abstract
OpenAlex
Ammad Naeem, Fatima Sial, Salman J. Khan, Aniqa Faraz et autres
Accès ouvert
2025
article
OpenAlex
Bahy Abofrekha, Jessica Schwartz, Chloé Lahoud, Ahmad Mustafa et autres
Background Antiphospholipid syndrome (APS) predisposes patients to thrombosis and cardiac valve lesions such as Libman-Sacks endocarditis. These vegetations are sterile yet can provide a nidus for infection; the risk of infective endocarditis (IE) and other serious infections in APS patients remains poorly …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Osamede Agho, Sara Tariq, Arshia Ahmed, Salman J. Khan et autres
Acute pericarditis with pericardial effusion caused by Lyme disease is very rare and requires excluding other more common possible causes of acute pericarditis. Common causes of acute pericarditis include viral and bacterial infections, connective tissue disorders such as rheumatoid arthritis, systemic lupus …
us, Nigéria
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Atif Saleem Butt, Muhammad Fareed Khalid, Ammad Naeem, Salman J. Khan et autres
e18160 Background: Induction chemotherapy (IC) has emerged as a promising approach in the management of locally advanced sinonasal carcinoma. Recent studies have demonstrated that IC can lead to significant tumor reduction, facilitating subsequent definitive treatments such as chemoradiotherapy (CRT) or surgery, and …
us
(code pays fourni par la source)